...
首页> 外文期刊>JAMA: the Journal of the American Medical Association >Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
【24h】

Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.

机译:原发性甲状腺功能减退合并左甲状腺素联合碘甲状腺素与单独使用左甲状腺素相比:一项随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Standard therapy for patients with primary hypothyroidism is replacement with synthetic thyroxine, which undergoes peripheral conversion to triiodothyronine, the active form of thyroid hormone. Within the lay population and in some medical communities, there is a perception that adding synthetic triiodothyronine, or liothyronine, to levothyroxine improves the symptoms of hypothyroidism despite insufficient evidence to support this practice. OBJECTIVE: To evaluate the benefits of treating primary hypothyroidism with levothyroxine plus liothyronine combination therapy vs levothyroxine monotherapy. DESIGN, SETTING, AND PATIENTS: Randomized, double-blind, placebo-controlled trial conducted from May 2000 to February 2002 at a military treatment facility that serves active duty and retired military personnel and their family members. The trial included a total of 46 patients aged 24 to 65 years with at least a 6-month history of treatment with levothyroxine for primary hypothyroidism. INTERVENTION: Patients received either their usual dose of levothyroxine (n = 23) or combination therapy (n = 23), in which their usual levothyroxine dose was reduced by 50 micro g/d and substituted with liothyronine, 7.5 micro g, taken twice daily for 4 months. MAIN OUTCOME MEASURES: Scores on a hypothyroid-specific health-related quality-of-life (HRQL) questionnaire, body weight, serum lipid levels, and 13 neuropsychological tests measured before and after treatment. RESULTS: Serum thyrotropin levels remained similar and within the normal range in both treatment groups from baseline to 4 months. Body weight and serum lipid levels did not change. The HRQL questionnaire scores improved significantly in both the control group (23%; P<.001) and the combination therapy group (12%; P =.02), but these changes were statistically similar (P =.54). In 12 of 13 neuropsychological tests, outcomes between groups were not significantly different; the 1 remaining test (Grooved Peg Board) showed better performance in the control group. CONCLUSION: Compared with levothyroxine alone, treatment of primary hypothyroidism with combination levothyroxine plus liothyronine demonstrated no beneficial changes in body weight, serum lipid levels, hypothyroid symptoms as measured by a HRQL questionnaire, and standard measures of cognitive performance.
机译:背景:原发性甲状腺功能减退症患者的标准疗法是用合成甲状腺素替代,该合成甲状腺素经过外周转化为甲状腺激素的活性形式三碘甲状腺素。在外来人口和某些医学界,人们普遍认为,尽管没有足够的证据支持左甲状腺素向甲状腺素中添加人工合成的三碘甲状腺素或碘甲状腺素可改善甲状腺功能减退的症状。目的:评估左甲状腺素联合碘甲状腺素联合疗法与左甲状腺素单药治疗原发性甲状腺功能减退的疗效。设计,地点和患者:2000年5月至2002年2月在为现役军人和退休军人及其家人服务的军事治疗设施中进行的随机,双盲,安慰剂对照试验。该试验共纳入46名年龄在24至65岁之间的患者,至少有6个月的左甲状腺素治疗原发性甲状腺功能减退的病史。干预:患者接受常规剂量的左甲状腺素(n = 23)或联合疗法(n = 23),其中常规左甲状腺素的剂量减少50微克/天,并用7.5微克碘甲状腺素替代,每天服用两次4个月。主要观察指标:治疗前后甲状腺功能减退相关的健康相关生活质量(HRQL)问卷,体重,血脂水平和13种神经心理学测试的得分。结果:从基线到4个月,两个治疗组的血清促甲状腺素水平保持相似并在正常范围内。体重和血脂水平没有改变。对照组(23%; P <.001)和联合治疗组(12%; P = .02)的HRQL问卷得分均显着提高,但这些变化在统计学上相似(P = .54)。在13项神经心理学测试中,有12项的结果在两组之间没有显着差异。其余1个测试(带槽钉板)在对照组中表现出更好的性能。结论:与单独使用左甲状腺素相比,左甲状腺素加碘甲状腺素联合治疗原发性甲状腺功能减退患者的体重,血脂水平,甲状腺功能减退症状(按HRQL调查表进行测量)和认知功能的标准指标均未见有益变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号